Compare DLB & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLB | SHC |
|---|---|---|
| Founded | 1965 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.0B |
| IPO Year | 2004 | 2020 |
| Metric | DLB | SHC |
|---|---|---|
| Price | $50.98 | $17.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $90.75 | $20.33 |
| AVG Volume (30 Days) | 870.9K | ★ 2.5M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | ★ 1.54 | 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $6.22 | $7.51 |
| Revenue Next Year | $3.84 | $6.00 |
| P/E Ratio | ★ $33.21 | $199.22 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $50.61 | $10.94 |
| 52 Week High | $76.91 | $19.85 |
| Indicator | DLB | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 72.77 |
| Support Level | $50.73 | $15.14 |
| Resistance Level | $65.73 | $19.85 |
| Average True Range (ATR) | 1.56 | 0.46 |
| MACD | 0.11 | 0.19 |
| Stochastic Oscillator | 14.25 | 93.38 |
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.